National VisionvsMerck & Company

EYE and MRK stock compared: price, dividend, valuation and results, from SEC filings.

EYE

National Vision Holdings, Inc.

$18.74

Value $1.5B

+2.43%
EYE's page

MRK

Merck & Company, Inc.

$144.46

Value $357B

-2.23%
MRK's page

National Vision (EYE) has a market value of $1.5B and Merck & Company (MRK) $357B. Over the last year, with dividends, EYE moved -20.9% and MRK +60.0%. The P/E is 22.5 for EYE and 145.6 for MRK. Dividend yield: EYE none, MRK 2.35%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    EYE$1.5B

    MRK$357B

    MRK is 240 times EYE

  • Revenue, 12 months

    EYE$2.1B

    MRK$67.4B

    MRK is 33 times EYE

  • Net income, 12 months

    EYE$66M

    MRK$2.5B

    MRK is 37 times EYE

  • Operating margin

    EYE5.1%

    MRK–

  • ROIC

    EYE6.7%

    MRK3.9%

    2.8 points apart

  • P/E

    EYE22.5

    MRK145.6

    MRK is 6.5 times EYE

  • Dividend yield

    EYE0.0%

    MRK2.4%

    2.4 points apart

  • 5-year return

    EYE-62.0%

    MRK+101.1%

    163.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

EYE-62.0%

MRK+101.1%

10020020222023202420252026
Returns by period
PeriodEYEWith dividendsMRKWith dividends
1 year since November 14, 2025-20.9%Price -20.9%+60.0%Price +55.5%
3 years since November 16, 2023-2.0%-0.7% a yearPrice -2.0%+55.2%+15.8% a yearPrice +41.6%
5 years since November 15, 2021-62.0%-17.6% a yearPrice -62.0%+101.1%+15.0% a yearPrice +72.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

EYENational VisionMRKMerck & Company

Valuation

EYEMRK
Valuation
Price$18.74$144.46
Market value$1.5B$357B
Enterprise value (EV)$1.7B$401B
P/E22.5145.6
P/E, 5-year median70.114.8
P/B1.78.0
EV/EBIT16.084.3
Free cash flow yield4.6%4.1%

Results and growth

EYEMRK
Results and growth
Revenue, 12 months$2.1B$67.4B
Net income, 12 months$66M$2.5B
Free cash flow, 12 months$68M$14.7B
Earnings per share, 12 months$0.81$0.98
Revenue growth, year on year9.0%1.3%
Revenue growth a year, past+3.0%over 5 years+9.4%over 5 years
EPS growth a year, past-3.4%over 5 years+21.2%over 5 years

Margins and returns on capital

EYEMRK
Margins and returns on capital
Gross margin58.8%71.8%
Operating margin5.1%–
Net margin3.2%3.6%
ROIC6.7%3.9%
ROE7.5%5.2%

Balance sheet

EYEMRK
Balance sheet
Cash$60M$9.7B
Total debt$688M$53.8B
Net debt / EBITDA0.95.7
Interest cover–2.4×

Dividends and buybacks

EYEMRK
Dividends and buybacks
Dividend yield–2.4%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield0.2%1.4%
Shareholder yield0.2%3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: EYE or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, National Vision or Merck & Company?

By market value, Merck & Company ($357B) is about 239.9 times National Vision ($1.5B), at today's prices.

How did EYE and MRK stock do over the last 5 years?

Since November 15, 2021, EYE's price moved -62.0% and MRK's +72.6%. With dividends: EYE -62.0% (-17.6% a year), MRK +101.1% (+15.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, EYE or MRK?

The dividend yield at today's price is none for National Vision and 2.35% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of EYE and MRK?

At today's price, the P/E is 22.5 for EYE and 145.6 for MRK. The median of the last five years was 70.1 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, National Vision or Merck & Company?

Over the last twelve months, the net margin was 3.2% for National Vision and 3.6% for Merck & Company, and the operating margin 5.1% and –. Revenue was $2.1B and $67.4B.

Which is the better investment, National Vision or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.